Skip to content

GCSF

DRUG16 trials

Sponsors

Hospira UK Ltd, Northwestern University, Massachusetts General Hospital, Tianjin SinoBiotech Ltd., National University Hospital, Singapore

Conditions

Acute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Acute-On-Chronic Liver FailureAlcoholic HepatitisCervix CancerChemotherapy-induced NeutropeniaChronic Granulomatous DiseaseDecompensated Cirrhosis

Phase 1

Phase 2

Meloxicam vs Placebo for Mobilization
CompletedNCT02003625
Massachusetts General HospitalHematopoietic Stem Cells, Hodgkin's Lymphoma, Multiple Myeloma +1
Start: 2013-10-31End: 2019-04-30Updated: 2020-05-18
Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
CompletedNCT02465801
Tianjin SinoBiotech Ltd.Chemotherapy-induced Neutropenia
Start: 2014-12-16End: 2016-04-26Updated: 2017-07-18
Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
CompletedNCT03251768
Tianjin SinoBiotech Ltd.Chemotherapy-induced Neutropenia
Start: 2017-10-19End: 2019-04-24Updated: 2019-09-13
Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients
NCT03547830
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyChronic Granulomatous Disease
Start: 2019-04-13End: 2023-01-01Target: 17Updated: 2019-09-17
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
Active, not recruitingNCT04872595
Memorial Sloan Kettering Cancer CenterAcute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Start: 2021-04-30End: 2026-04-30Updated: 2025-09-04
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Active, not recruitingNCT05498220
UNC Lineberger Comprehensive Cancer CenterDiffuse Large B-cell Lymphoma
Start: 2023-02-17End: 2026-11-07Updated: 2025-09-02
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
RecruitingNCT07188090
Thomas Jefferson UniversityHodgkin Lymphoma, Multiple Myeloma, Non-hodgkin Lymphoma
Start: 2025-10-16End: 2028-06-30Target: 100Updated: 2025-11-28

Phase 3

Phase 4

Unknown Phase

Related Papers